Misonix Announces Approval of Sonablate, Neuroaspirator Products

Misonix, a developer of ultrasonic medical device technology for the treatment of cancer and other healthcare purposes, announced that both the Sonablate 500 product used for the treatment of prostate cancer and its FS1000 Neuroaspirator for soft tissue removal used primarily in neurosurgery have received approval from the Russian Federation. This approval certifies that the products are fully registered and certified for sale and use for their stated applications within the Russian Federation.
Yahoo News